What You Should Know:
- Today, Cerner announced the launch of Cerner Enviza, a new operating unit that offers solutions to help bring clarity to multi-dimensional data through real-world evidence and insights.
- Cerner Enviza℠ aims to accelerate the discovery, development and delivery of extraordinary insights and therapies to improve everyday health for all people globally. By combining decades of healthcare innovation, life sciences knowledge and collaborative research, Cerner
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
FDA Selects Aetion Evidence Platform to Assess In-Patient COVID-19 Treatments
What You Should Know:
- Aetion, a NYC-based leading real-world evidence (RWE) company, announced that the U.S. Food and Drug Administration (FDA) has contracted with them to use their Aetion Evidence Platform® to rapidly assess in-patient COVID-19 treatments and advance regulatory science to help determine when, where and how to use RWD.
- This project is designed to demonstrate how using a platform-based approach
Read More
3 Ways Decentralized Clinical Trials Can Expand Diversity & Improve Participation Rates
I consider myself living proof of the American dream. In 1888, my great, great grandfather purchased a farm, Coleman Crest, that is still in our family today. Understanding his story and what he had to overcome during that period in history has given me such a great foundation and what still inspires me today.
My passion for chemistry began when I was a child. At a young age, I was diagnosed with a chronic illness and when things got tough, it was my pharmacist who gave me hope and
Read More
3 Ways to Address Gender and Racial Bias in Clinical Trials
I have dedicated my career to clinical research and making strides to advance modern medicine. In the work I do as a clinical researcher, we are addressing racial and gender biases that exist today in clinical trials. For example, in cardiovascular disease—my area of study—we know that women’s symptoms present differently than men and yet their symptoms have often gone undiagnosed or dismissed by physicians.
It is well documented that communities of color have historically been mistreated by
Read More
Lightship Raises $40M to Bring Decentralized Clinical Trials at Scale
What You Should Know:
- Lightship, a virtual-first provider of clinical trials, today announced that it has raised $40M to create access to clinical research for all patients and improving diversity among patient groups taking part in clinical trials around the world led by Define Ventures and Brook Byers, with participation from Khosla Ventures, McKesson Ventures and Marc Benioff’s TIME Ventures. This round of investment follows $20M of funding that Lightship announced in February 2020 to
Read More
3 Ways Digital Health is Transforming Decentralized Clinical Trials
Decentralized Clinical Trials (DCTs) have been gaining steam over the last decade, but it was the COVID-19 pandemic that cast its advantages into the limelight. Sponsors benefit by creating efficiencies virtually throughout drug discovery, research, and treatment phases. However, the greatest long-term benefactors will ultimately be the patients.
Many aspects of traditional clinical trials are inconvenient for potential candidates, including the commute distance to trial sites, time
Read More
RWE: Supporting Regulatory Submissions with Real-World Evidence
In 2016, the 21st Century Cures Act was signed into law, mandating that the FDA “establish a program to evaluate the use of real-world evidence (RWE) to help support the approval of new indications for a drug and to help to support or satisfy post-approval study requirements.” Along with advances in the availability and quality of real-world data (RWD) from sources like electronic health records (EHRs), registries, medical claims and pharmacy data, the Cures Act has been a catalyst for increased
Read More
Medidata, Labcorp Partner to Expand Decentralized Clinical Trials for Digital Biomarker Discovery
What You Should Know:
- Medidata, a Dassault Systèmes company, today announced a first-of-its-kind partnership with Labcorp using the Medidata Sensor Cloud to introduce a new model to advance the use of medical-grade sensors in clinical trials and accelerate biomarker discovery.
- As part of the partnership, Medidata will receive and process medical-grade sensor data within drug, vaccine and device trials across Labcorp Drug Development’s clinical trial portfolio,
Read More
EHR Data Reveals COVID-19 Vaccines Effective in Preventing Hospitalizations, ER Visits
What You Should Know:
- Real world evidence from electronic medical records (EHR) data reveals the COVID-19 vaccines are highly effective at preventing hospitalizations, emergency department visits and intensive care admissions due to the virus, according to a study just published in the New England Journal of Medicine (NEJM).
- The study, “Effectiveness of COVID-19 Vaccines in Preventing Ambulatory and Inpatient Care” analyzes actual data from hospitals around the US and shows
Read More
Cedars-Sinai Cancer Launches ‘Molecular Twin’ Initiative for Precision Cancer Treatment
What You Should Know:
- Cedars-Sinai Cancer and Tempus, a provider of artificial intelligence and precision medicine, are harnessing the power of big data and AI to design personalized cancer treatment options by creating virtual replicas of patients' DNA, RNA, protein and other information to help identify the most effective approach to each individual's disease.
- By creating these "molecular twins," scientists can genetically classify cancer genes and proteins of particular tumors
Read More
